REGENERON PHARMACEUTICALS, INC. Increase (Decrease) in Inventories
REGENERON PHARMACEUTICALS, INC. (REGN) reported Increase (Decrease) in Inventories of $1.60 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-07-30
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was $28.20M, a 33.65% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$26.60M, a 117.47% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$2.10M, a 101.78% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was $82.60M, a 49.76% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in inventories for fiscal 2025 was $275.30M, a 55.58% decline from fiscal 2024.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in inventories for fiscal 2024 was $619.70M, a 128.08% increase from fiscal 2023.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in inventories for fiscal 2023 was $271.70M, a 60.99% decline from fiscal 2022.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in inventories for fiscal 2022 was $696.50M, a 40.91% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $28.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $1.60M 10-Q · filed 2026-07-30 | -$500.00K derived: sum of 3 quarters · filed 2026-07-30 | $82.10M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | -$26.60M 10-Q · filed 2026-04-29 | -$28.70M derived: sum of 2 quarters · filed 2026-04-29 | $53.90M derived: sum of 3 quarters · filed 2026-04-29 | $96.40M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | -$2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $80.50M derived: sum of 2 quarters · filed 2026-02-04 | $123.00M derived: sum of 3 quarters · filed 2026-07-30 | $275.30M 10-K · filed 2026-02-04 | ||||
| 2025-09-30 | $82.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $125.10M derived: sum of 2 quarters · filed 2026-07-30 | $277.40M 10-Q · filed 2025-10-28 | $395.10M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $42.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $194.80M 10-Q · filed 2026-07-30 | $312.50M derived: sum of 3 quarters · filed 2026-07-30 | $476.90M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $152.30M 10-Q · filed 2026-04-29 | $270.00M derived: sum of 2 quarters · filed 2026-04-29 | $434.40M derived: sum of 3 quarters · filed 2026-04-29 | $616.20M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $117.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $282.10M derived: sum of 2 quarters · filed 2026-02-04 | $463.90M derived: sum of 3 quarters · filed 2026-02-04 | $619.70M 10-K · filed 2026-02-04 | ||||
| 2024-09-30 | $164.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $346.20M derived: sum of 2 quarters · filed 2025-10-28 | $502.00M 10-Q · filed 2025-10-28 | $549.30M derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2024-06-30 | $181.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $337.60M 10-Q · filed 2025-08-01 | $384.90M derived: sum of 3 quarters · filed 2026-02-04 | $462.10M derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2024-03-31 | $155.80M 10-Q · filed 2025-04-29 | $203.10M derived: sum of 2 quarters · filed 2026-02-04 | $280.30M derived: sum of 3 quarters · filed 2026-02-04 | $380.70M derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2023-12-31 | $47.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $124.50M derived: sum of 2 quarters · filed 2026-02-04 | $224.90M derived: sum of 3 quarters · filed 2026-02-04 | $271.70M 10-K · filed 2026-02-04 | ||||
| 2023-09-30 | $77.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $177.60M derived: sum of 2 quarters · filed 2024-10-31 | $224.40M 10-Q · filed 2024-10-31 | $368.70M derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2023-06-30 | $100.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $147.20M 10-Q · filed 2024-08-01 | $291.50M derived: sum of 3 quarters · filed 2025-02-05 | $515.00M derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2023-03-31 | $46.80M 10-Q · filed 2024-05-02 | $191.10M derived: sum of 2 quarters · filed 2025-02-05 | $414.60M derived: sum of 3 quarters · filed 2025-02-05 | $654.70M derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2022-12-31 | $144.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-05 | $367.80M derived: sum of 2 quarters · filed 2025-02-05 | $607.90M derived: sum of 3 quarters · filed 2025-02-05 | $696.50M 10-K · filed 2025-02-05 | ||||
| 2022-09-30 | $223.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $463.60M derived: sum of 2 quarters · filed 2023-11-02 | $552.20M 10-Q · filed 2023-11-02 | $715.90M derived: sum of 4 quarters · filed 2024-02-05 | ||||
| 2022-06-30 | $240.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $328.70M 10-Q · filed 2023-08-03 | $492.40M derived: sum of 3 quarters · filed 2024-02-05 | $601.50M derived: sum of 4 quarters · filed 2024-02-05 | ||||
| 2022-03-31 | $88.60M 10-Q · filed 2023-05-04 | $252.30M derived: sum of 2 quarters · filed 2024-02-05 | $361.40M derived: sum of 3 quarters · filed 2024-02-05 | $330.10M derived: sum of 4 quarters · filed 2024-02-05 | ||||
| 2021-12-31 | $163.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-05 | $272.80M derived: sum of 2 quarters · filed 2024-02-05 | $241.50M derived: sum of 3 quarters · filed 2024-02-05 | $494.30M 10-K · filed 2024-02-05 | ||||
| 2021-09-30 | $109.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $77.80M derived: sum of 2 quarters · filed 2022-11-03 | $330.60M 10-Q · filed 2022-11-03 | $457.60M derived: sum of 4 quarters · filed 2023-02-06 | ||||
| 2021-06-30 | -$31.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $221.50M 10-Q · filed 2022-08-03 | $348.50M derived: sum of 3 quarters · filed 2023-02-06 | $517.50M derived: sum of 4 quarters · filed 2023-02-06 | ||||
| 2021-03-31 | $252.80M 10-Q · filed 2022-05-04 | $379.80M derived: sum of 2 quarters · filed 2023-02-06 | $548.80M derived: sum of 3 quarters · filed 2023-02-06 | $711.40M derived: sum of 4 quarters · filed 2023-02-06 | ||||
| 2020-12-31 | $127.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-06 | $296.00M derived: sum of 2 quarters · filed 2023-02-06 | $458.60M derived: sum of 3 quarters · filed 2023-02-06 | $529.40M 10-K · filed 2023-02-06 | ||||
| 2020-09-30 | $169.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $331.60M derived: sum of 2 quarters · filed 2021-11-04 | $402.40M 10-Q · filed 2021-11-04 | $510.70M derived: sum of 4 quarters · filed 2022-02-07 | ||||
| 2020-06-30 | $162.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $233.40M 10-Q · filed 2021-08-05 | $341.70M derived: sum of 3 quarters · filed 2022-02-07 | $400.70M derived: sum of 4 quarters · filed 2022-02-07 | ||||
| 2020-03-31 | $70.80M 10-Q · filed 2021-05-06 | $179.10M derived: sum of 2 quarters · filed 2022-02-07 | $238.10M derived: sum of 3 quarters · filed 2022-02-07 | $347.70M derived: sum of 4 quarters · filed 2022-02-07 | ||||
| 2019-12-31 | $108.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-07 | $167.30M derived: sum of 2 quarters · filed 2022-02-07 | $276.90M derived: sum of 3 quarters · filed 2022-02-07 | $335.50M 10-K · filed 2022-02-07 | ||||
| 2019-09-30 | $59.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $168.60M derived: sum of 2 quarters · filed 2020-11-05 | $227.20M 10-Q · filed 2020-11-05 | $333.50M derived: sum of 4 quarters · filed 2021-02-08 | ||||
| 2019-06-30 | $109.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $168.20M 10-Q · filed 2020-08-05 | $274.50M derived: sum of 3 quarters · filed 2021-02-08 | $374.00M derived: sum of 4 quarters · filed 2021-02-08 | ||||
| 2019-03-31 | $58.60M 10-Q · filed 2020-05-05 | $164.90M derived: sum of 2 quarters · filed 2021-02-08 | $264.40M derived: sum of 3 quarters · filed 2021-02-08 | $357.70M derived: sum of 4 quarters · filed 2021-02-08 | ||||
| 2018-12-31 | $106.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-08 | $205.80M derived: sum of 2 quarters · filed 2021-02-08 | $299.10M derived: sum of 3 quarters · filed 2021-02-08 | $387.90M 10-K · filed 2021-02-08 | ||||
| 2018-09-30 | $99.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $192.80M derived: sum of 2 quarters · filed 2019-11-05 | $281.60M 10-Q · filed 2019-11-05 | $281.62M 10-Q · filed 2018-11-06 | $360.15M derived: sum of 4 quarters · filed 2020-02-07 | |||
| 2018-06-30 | $93.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $182.10M 10-Q · filed 2019-08-06 | $260.65M derived: sum of 3 quarters · filed 2020-02-07 | $344.76M derived: sum of 4 quarters · filed 2020-02-07 | ||||
| 2018-03-31 | $88.80M 10-Q · filed 2019-05-07 | $88.76M 10-Q · filed 2018-05-03 | $167.35M derived: sum of 2 quarters · filed 2020-02-07 | $251.46M derived: sum of 3 quarters · filed 2020-02-07 | $333.26M derived: sum of 4 quarters · filed 2020-02-07 | |||
| 2017-12-31 | $78.56M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | $162.66M derived: sum of 2 quarters · filed 2020-02-07 | $244.46M derived: sum of 3 quarters · filed 2020-02-07 | $314.20M 10-K · filed 2020-02-07 | $314.19M 10-K · filed 2018-02-08 | |||
| 2017-09-30 | $84.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $165.90M derived: sum of 2 quarters · filed 2018-11-06 | $235.65M 10-Q · filed 2018-11-06 | $285.74M derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2017-06-30 | $81.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $151.54M 10-Q · filed 2018-08-02 | $201.64M derived: sum of 3 quarters · filed 2019-02-07 | $228.46M derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2017-03-31 | $69.74M 10-Q · filed 2018-05-03 | $119.84M derived: sum of 2 quarters · filed 2019-02-07 | $146.66M derived: sum of 3 quarters · filed 2019-02-07 | $157.28M derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2016-12-31 | $50.09M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-07 | $76.91M derived: sum of 2 quarters · filed 2019-02-07 | $87.54M derived: sum of 3 quarters · filed 2019-02-07 | $149.80M 10-K · filed 2019-02-07 | $149.78M 10-K · filed 2017-02-09 | |||
| 2016-09-30 | $26.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $37.44M derived: sum of 2 quarters · filed 2017-11-08 | $99.71M 10-Q · filed 2017-11-08 | $145.28M derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2016-06-30 | $10.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $72.89M 10-Q · filed 2017-08-03 | $118.46M derived: sum of 3 quarters · filed 2018-02-08 | $139.12M derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2016-03-31 | $62.26M 10-Q · filed 2017-05-04 | $107.83M derived: sum of 2 quarters · filed 2018-02-08 | $128.50M derived: sum of 3 quarters · filed 2018-02-08 | $168.65M derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2015-12-31 | $45.57M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-08 | $66.23M derived: sum of 2 quarters · filed 2018-02-08 | $106.39M derived: sum of 3 quarters · filed 2018-02-08 | $111.83M 10-K · filed 2018-02-08 | ||||
| 2015-09-30 | $20.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $60.82M derived: sum of 2 quarters · filed 2016-11-04 | $66.25M 10-Q · filed 2016-11-04 | $81.46M 10-Q · filed 2015-11-04 | $72.28M derived: sum of 4 quarters · filed 2017-02-09 | |||
| 2015-06-30 | $40.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $45.59M 10-Q · filed 2016-08-04 | $49.85M 10-Q · filed 2015-08-04 | $51.62M derived: sum of 3 quarters · filed 2017-02-09 | $65.24M derived: sum of 4 quarters · filed 2017-02-09 | |||
| 2015-03-31 | $5.43M 10-Q · filed 2016-05-05 | $5.93M 10-Q · filed 2015-05-07 | $11.46M derived: sum of 2 quarters · filed 2017-02-09 | $25.09M derived: sum of 3 quarters · filed 2017-02-09 | $46.83M derived: sum of 4 quarters · filed 2017-02-09 | |||
| 2014-12-31 | $6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-09 | $19.65M derived: sum of 2 quarters · filed 2017-02-09 | $41.40M derived: sum of 3 quarters · filed 2017-02-09 | $56.95M 10-K · filed 2017-02-09 | $60.90M 10-K · filed 2015-02-12 | |||
| 2014-09-30 | $13.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $35.37M derived: sum of 2 quarters · filed 2015-11-04 | $50.92M 10-Q · filed 2015-11-04 | $62.13M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-06-30 | $21.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $37.30M 10-Q · filed 2015-08-04 | $48.51M derived: sum of 3 quarters · filed 2016-02-11 | $54.11M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-03-31 | $15.55M 10-Q · filed 2015-05-07 | $26.76M derived: sum of 2 quarters · filed 2016-02-11 | $32.36M derived: sum of 3 quarters · filed 2016-02-11 | $45.92M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2013-12-31 | $11.21M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $16.81M derived: sum of 2 quarters · filed 2016-02-11 | $30.38M derived: sum of 3 quarters · filed 2016-02-11 | $47.96M 10-K · filed 2016-02-11 | ||||
| 2013-09-30 | $5.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $19.16M derived: sum of 2 quarters · filed 2014-11-04 | $36.74M 10-Q · filed 2014-11-04 | |||||
| 2013-06-30 | $13.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $31.14M 10-Q · filed 2014-08-05 | ||||||
| 2013-03-31 | $17.58M 10-Q · filed 2014-05-08 | |||||||
| 2012-12-31 | $28.93M 10-K · filed 2015-02-12 | |||||||
| 2011-12-31 | $14.09M 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |